Literature DB >> 9765395

Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue.

D Duan1, P Sharma, J Yang, Y Yue, L Dudus, Y Zhang, K J Fisher, J F Engelhardt.   

Abstract

Adeno-associated viral (AAV) vectors have demonstrated great utility for long-term gene expression in muscle tissue. However, the mechanisms by which recombinant AAV (rAAV) genomes persist in muscle tissue remain unclear. Using a recombinant shuttle vector, we have demonstrated that circularized rAAV intermediates impart episomal persistence to rAAV genomes in muscle tissue. The majority of circular intermediates had a consistent head-to-tail configuration consisting of monomer genomes which slowly converted to large multimers of >12 kbp by 80 days postinfection. Importantly, long-term transgene expression was associated with prolonged (80-day) episomal persistence of these circular intermediates. Structural features of these circular intermediates responsible for increased persistence included a DNA element encompassing two viral inverted terminal repeats (ITRs) in a head-to-tail orientation, which confers a 10-fold increase in the stability of DNA following incorporation into plasmid-based vectors and transfection into HeLa cells. These studies suggest that certain structural characteristics of AAV circular intermediates may explain long-term episomal persistence with this vector. Such information may also aid in the development of nonviral gene delivery systems with increased efficiency.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765395      PMCID: PMC110267     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

Review 1.  Use of adeno-associated virus as a general transduction vector for mammalian cells.

Authors:  N Muzyczka
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

2.  A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication.

Authors:  R J Samulski; L S Chang; T Shenk
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

3.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

Review 4.  Form and function of retroviral proviruses.

Authors:  H E Varmus
Journal:  Science       Date:  1982-05-21       Impact factor: 47.728

5.  Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction.

Authors:  J Bennett; D Duan; J F Engelhardt; A M Maguire
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-12       Impact factor: 4.799

6.  Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression.

Authors:  R J Samulski; L S Chang; T Shenk
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

7.  Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein.

Authors:  A Beaton; P Palumbo; K I Berns
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

8.  Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells.

Authors:  A K Cheung; M D Hoggan; W W Hauswirth; K I Berns
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

9.  Adeno-associated virus general transduction vectors: analysis of proviral structures.

Authors:  S K McLaughlin; P Collis; P L Hermonat; N Muzyczka
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

10.  Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination.

Authors:  R M Kotin; R M Linden; K I Berns
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  192 in total

1.  Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination.

Authors:  J Yang; W Zhou; Y Zhang; T Zidon; T Ritchie; J F Engelhardt
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Bad for cats, good for humans? Modified feline immunodeficiency virus for gene therapy.

Authors:  R G Crystal
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 3.  Adeno-associated virus vectors and hematology.

Authors:  D W Russell; M A Kay
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

4.  Kinetics of recombinant adeno-associated virus-mediated gene transfer.

Authors:  A K Malik; P E Monahan; D L Allen; B G Chen; R J Samulski; K Kurachi
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

5.  Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy.

Authors:  Z Yan; Y Zhang; D Duan; J F Engelhardt
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

6.  The persistence of alien genomes.

Authors:  P Tattersall
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

7.  Involvement of cellular double-stranded DNA break binding proteins in processing of the recombinant adeno-associated virus genome.

Authors:  L Zentilin; A Marcello; M Giacca
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

8.  Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo.

Authors:  H Nakai; T A Storm; M A Kay
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

9.  Genetic fate of recombinant adeno-associated virus vector genomes in muscle.

Authors:  Bruce C Schnepp; K Reed Clark; Dori L Klemanski; Christina A Pacak; Philip R Johnson
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

10.  Adeno-associated viruses undergo substantial evolution in primates during natural infections.

Authors:  Guangping Gao; Mauricio R Alvira; Suryanarayan Somanathan; You Lu; Luk H Vandenberghe; John J Rux; Roberto Calcedo; Julio Sanmiguel; Zahra Abbas; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.